Narrow-moat Cencora started the year on a strong footing after delivering solid first-quarter results. Total sales of $81.5 billion were up 12.8% year over year and came ahead of our $78.1 billion ...

Feb 5 (Reuters) - Drug distributor Cencora (COR.N), opens new tab raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines. The Conshohocken ...

(RTTNews) - Cencora, Inc. (COR) reported earnings for first quarter that decreased from last year but beat the Street estimates. The company's bottom line came in at $488.60 million, or $2.50 per ...